TCF4 and hepatocellular carcinoma: In addition, the binding of TCF4 to β-catenin in HCC cells treated with doxorubicin was assessed in the presence or absence of salinomycin for 48 h, and mRNA expression levels from β-catenin/TCF target genes were measured.